SCHEMBL13487205

SCHEMBL13487205

CC1(C)c2ccccc2-c2c(-c3c4ccccc4c(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c4ccc(-c5cccc6ccccc56)cc34)cccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MCL1 Q07820 1/20 0.34
ACMSD Q8TDX5 1/20 0.34
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487137 0.92 L3MBTL1 (0.32) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487206 0.91 MEN1 (0.35) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487311 0.90 KDM4E (0.34) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487393 0.89 PDK2 (0.33) KDM4EALDH1A1MAPTHPGDL3MBTL1
SCHEMBL13488016 0.88 ALDH1A1 (0.36) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487631 0.88 ALDH1A1 (0.36) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487175 0.88 HTR2C (0.36) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487191 0.87 MCL1 (0.36) ALDH1A1MAPTSMN1; SMN2MCL1ACMSD
SCHEMBL13487068 0.87 MEN1 (0.38) KDM4EALDH1A1MAPTHPGDMAPK1
SCHEMBL13487178 0.86 MCL1 (0.32) MCL1ACMSDCHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 KDM4E 3671/4885ALDH1A1 101/4885MAPT 2219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.